 |
L-baclofen |
|---|---|
| Trade Name | Neuralgon |
| Orphan Indication | Intractable spasticity in children with cerebral palsy |
| USA Market Approval | USA |
| USA Designation Date | 1992-01-30 00:00:00 |
| Sponsor | Osmotica Pharmaceutical Corp.;1205 Culbreth Drive, Suite 200;Wilmington, North Carolina, 28405 |
